An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Top results in this bookTable of Contents
Non-Hodgkin's Lymphoma: Diagnosis and Management.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 52.)
Coeliac Disease: Recognition, Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2015 Sep. (NICE Guideline, No. 20.)
WHO Guidelines for Indoor Air Quality: Selected Pollutants.
Geneva: World Health Organization; 2010.
Neutropenic Sepsis: Prevention and Management of Neutropenic Sepsis in Cancer Patients.
National Collaborating Centre for Cancer (UK).
London: National Institute for Health and Clinical Excellence (NICE); 2012 Sep. (NICE Clinical Guidelines, No. 151.)
Addendum to Haematological Cancers: improving outcomes (update).
London: National Institute for Health and Care Excellence (NICE); 2016 May.
Epcoritamab (Epkinly): CADTH Reimbursement Recommendation: Indication: Adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), not otherwise specified, DLBCL transformed from indolent lymphoma, high grade B-cell lymphoma, primary mediastinal B-cell lymphoma or follicular lymphoma Grade 3B after two or more lines of systemic therapy and who have previously received or are unable to receive CAR-T cell therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jun.
Primary Care for Adults With HIV [Internet].
Kerr C, Dyer M, Vail RM, et al.
Baltimore (MD): Johns Hopkins University; 2024 Jul.
Suspected cancer: recognition and referral.
London: National Institute for Health and Care Excellence (NICE); 2023 Oct 24. (NICE Guideline, No. 12.)
Polatuzumab Vedotin (Polivy): CADTH Reimbursement Recommendation: Indication: Large B-cell lymphoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jan.
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda.
Washington (DC): National Academies Press (US); 2017 Jan 12.
Zanubrutinib (Brukinsa): CADTH Reimbursement Recommendation: Indication: For the treatment of patients with Waldenström macroglobulinemia [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021 Dec.
Chlormethine Gel (Ledaga): CADTH Reimbursement Recommendation: Indication: The topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in adult patients who have received prior skin-directed therapy [Internet].
Ravulizumab (Ultomiris): CADTH Reimbursement Reviews and Recommendations: Therapeutic area: Paroxysmal nocturnal hemoglobinuria [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr.
Nelarabine (Atriance): CADTH Reimbursement Recommendation: Indication: Nelarabine (Atriance) for addition to front-line multiagent therapy of pediatric, adolescent, and young adult patients (aged 1 year to 30 years at diagnosis) with intermediate- or high-risk T-cell acute lymphoblastic leukemia [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Oct.
Spinal metastases and metastatic spinal cord compression.
London: National Institute for Health and Care Excellence (NICE); 2023 Sep 6. (NICE Clinical Guidelines, No. 234.)
Early and locally advanced breast cancer: diagnosis and management.
London: National Institute for Health and Care Excellence (NICE); 2024 Jan 16. (NICE Guideline, No. 101.)
Tisagenlecleucel (Kymriah): CADTH Reimbursement Recommendation: Indication: For the treatment of adult patients with relapsed or refractory grade 1, 2, or 3a follicular lymphoma after 2 or more lines of systemic therapy [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Sep.
Depression in Adults with a Chronic Physical Health Problem: Treatment and Management.
National Collaborating Centre for Mental Health (UK).
Leicester (UK): British Psychological Society (UK); 2010. (NICE Clinical Guidelines, No. 91.)
Ibrutinib (Imbruvica): CADTH Reimbursement Recommendation: Indication: Ibrutinib in combination with venetoclax for the treatment of adult patients with previously untreated chronic lymphocytic leukemia, including those with 17p deletion [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on